Transformation Manager, US Value & Access Strategy & Innovation
Amgen
Summary
Serve as a Transformation Manager within the US Value & Access Strategy & Innovation team, advancing a cross-functional transformation initiative focused on important business opportunities across US Value & Access.
Job description
Key Responsibilities
- Support assigned project workstreams from opportunity assessment and definition through solution development, business validation, launch readiness, and early adoption.
- Partner with business, product, data, analytics, technology, and functional teams to translate business needs into user scenarios, process requirements, workstream plans, and measures of success.
- Coordinate cross-functional activities, dependencies, and business-user input so delivery decisions reflect operational needs and user experience.
- Plan and support business validation, user acceptance testing, and pilot activities; coordinate participants, prepare scenarios, gather feedback, and track issues through resolution or escalation.
- Develop and maintain workstream materials, including plans, process maps, requirements, decision and action logs, risk and dependency trackers, test scenarios, and feedback summaries.
- Identify risks, gaps, and decisions that could affect delivery or business use; recommend next steps and raise matters requiring leadership direction.
- Help prepare teams for launch through readiness coordination, communications and training inputs, and early adoption support.
- Support change management by helping teams understand how new capabilities affect their work, identifying adoption risks, and preparing teams for change.
- Review user feedback and usage or performance information to identify improvement opportunities.
- Keep working teams and leaders informed about progress, issues, decisions, next steps, and workstream outcomes.
- Contribute to repeatable approaches and tools that improve readiness, validation, launch, and ongoing improvement.
Preferred Qualifications
- Collaborative, action-oriented approach with sound judgment about when to work independently or seek direction.
- Experience independently managing a defined workstream or project, including organizing activities, coordinating contributors, and tracking milestones.
- Experience defining business needs, processes, requirements, or measures of success.
- Experience contributing to an implementation, rollout, process change, or continuous-improvement effort.
- Strong organization, analytical thinking, and problem-solving skills.
- Strong written and verbal communication skills.
- Ability to work effectively with business and technical partners.
- Familiarity with Agile or other structured project or work-management approaches and collaboration tools.
- Experience in the pharmaceutical industry, particularly in market access, commercial operations, or a related function.
Requirements
- Doctorate degree; OR Master's degree and 2 years of relevant experience; OR Bachelor's degree and 4 years of relevant experience; OR Associate's degree and 8 years of relevant experience; OR High school diploma/GED and 10 years of relevant experience
- Relevant experience in business transformation, strategy, operations, change management, project management, consulting, product operations, data and analytics, or a related discipline
- Strong business transformation, problem-solving, stakeholder-management, and cross-functional collaboration capabilities
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-Based Long-Term Incentives
- Paid Time Off
- Company-Wide Shutdowns
- Remote & Hybrid Work
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.